“Gefitinib: A Pharmacoeconomic Profile of Its Use in Patients With Non Small Cell Lung Cancer EGFR+”. 2011. Farmeconomia. Health Economics and Therapeutic Pathways 12 (2): 77-85. https://doi.org/10.7175/fe.v12i2.73.